ADAM10 and hepatocellular carcinoma: In a cohort of 333 HCC patients, those carrying the ADAM10 rs514049 (AC + CC) variant were found to have a heightened susceptibility to develop lymph node metastasis, while individuals with the ADAM10 rs653765 variant were more prone to developing distant metastasis (47).